Press release
Strong Growth Ahead: Antisense & RNAi Therapeutics Market Size To Grow At Arecord 13.1% Cagr By 2029
Antisense & RNAi Therapeutics
How Big Is the Antisense & RNAi Therapeutics Market Size Expected to Be by 2034?
The market size of antisense & RNAi therapeutics has seen considerable expansion in the past years. This substantial growth will see it scale from $1.75 billion in 2024 to an estimated $1.94 billion in 2025, with a CAGR of 11.2%. This prior growth can be linked to an increase in funding, technological advancements, a surge in healthcare spending, the rapid rise of the elderly population, and economic growth in emergent markets.
The market size for antisense and RNAi therapeutics is anticipated to experience a swift expansion in the coming years, with a projected worth of $3.18 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 13.1%. The anticipated rise during the forecast period is due to increased access to healthcare, a surge in cancer cases, and a heightened demand for antisense and RNAi therapeutics as a response to the COVID-19 pandemic. The forecast period is expected to display trends such as focused research and development of RNA therapeutics for rare diseases, utilization of nanoparticles, progress in producing new and enhanced antisense and RNAi therapeutics, and partnerships with various companies to spur product innovation and stimulate revenue generation.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
What Are the Emerging Segments Within the Antisense & RNAi Therapeutics Market?
The antisense & RNAi therapeutics market covered in this report is segmented -
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
What Long-Term Drivers Are Shaping Antisense & RNAi Therapeutics Market Trends?
The escalating occurrence of coronary artery ailments, neurodegenerative disorders, and infectious diseases is envisaged to stimulate the demand for the antisense & RNAi therapeutics market. Gene suppression techniques such as RNA interference and antisense oligonucleotides are employed in the treatment of different neurodegenerative conditions by restoring defective genes. To exemplify, in January 2024, the American Heart Association, a US-based agency, disclosed in a report that the death rate from cardiovascular diseases climbed to 233.3 per 100,000, marking a 4.0% surge from the preceding year when adjusted for age. Therefore, the increasing incidence of various neurodegenerative and infectious diseases is predicted to propel antisense & RNAi therapeutics market expansion.
Who Are the Top Competitors in Key Antisense & RNAi Therapeutics Market Segments?
Major companies operating in the antisense & RNAi therapeutics market include Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical
What Antisense & RNAi Therapeutics Market Trends Are Gaining Traction Across Different Segments?
Key players in the antisense and RNAi therapeutics market are using strategic initiatives like collaborations and partnerships to maintain their stand in the increasingly competitive industry. The strategy involves the cooperation of several companies to reach a mutual goal or aim. For example, in January 2023, Orbit Discovery Limited, a services provider for peptide discovery based in the US, established a partnership with SanegeneBio Inc., a UK-based business that creates novel RNAi-based medicines. The purpose of the partnership is to identify tissue-specific deliveries of RNA therapeutics for efficient gene knockdown, in an effort to build an advanced RNAi therapeutics portfolio. The partnership includes identification of targets and internalization studies based on cells, with Sanegene provided an option to continue the development of targets that arise from the screening procedures, using Orbit's unique technology to quickly discover peptide leads. Orbit Discovery's exclusive peptide display engine permits the screening of extensive peptide libraries, which in turn permits faster discovery of appropriate peptide leads guided by affinity and functional screens.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report
Which Regions Are Becoming Hubs for Antisense & RNAi Therapeutics Market Innovation?
North America was the largest region in the antisense & RNAi therapeutics market in 2024. The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Antisense & RNAi Therapeutics Market?
2. What is the CAGR expected in the Antisense & RNAi Therapeutics Market?
3. What Are the Key Innovations Transforming the Antisense & RNAi Therapeutics Industry?
4. Which Region Is Leading the Antisense & RNAi Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Antisense & RNAi Therapeutics Market Size To Grow At Arecord 13.1% Cagr By 2029 here
News-ID: 4002731 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
